BioMed Nexus Industry Directory

Contract Research
Organizations

The definitive directory of contract research organizations (CROs), spanning full-service global CROs, early-phase and Phase 1 units, oncology specialists, bioanalytical and central labs, regulatory CROs, decentralized trial providers, and specialty niche CROs. Curated for biotechs outsourcing trials, sponsors sourcing lab and regulatory services, and business development leads mapping the CRO landscape.

143
CROs Listed
7
Categories
$139B
CRO Market Size (2029)
100,000 Directory Views
65,000+ Newsletter Subscribers
1.1M Monthly Impressions
Distributed via the BioMed Nexus Daily Brief
Directory Contract Research Organizations

BioMed Nexus tracks 143 contract research organizations (CROs) across 7 categories: full service, early phase, oncology specialist, bioanalytical & lab, regulatory, decentralized trials, and specialty & niche. The directory covers the largest global CROs, including IQVIA, ICON, Fortrea, Parexel, Medpace and Charles River, alongside specialist providers. Last updated July 2026

Become a Featured Partner

Priority placement at the top of the directory, a dedicated landing page, and a featured newsletter segment reaching 65,000+ subscribers. Limited spots available.

All Listed CROs / 143 organizations

CRO Database
Syneos HealthUpgrade listing →
PPD (Thermo Fisher)Upgrade listing →
CTI Clinical Trial ServicesUpgrade listing →
Advanced ClinicalUpgrade listing →
Worldwide Clinical TrialsUpgrade listing →
Cromos PharmaUpgrade listing →
ProRelix ResearchUpgrade listing →
Confidence PharmaceuticalUpgrade listing →
TRI (Technical Resources Intl)Upgrade listing →
Firma Clinical ResearchUpgrade listing →
Emmes CompanyUpgrade listing →
PCYC (Pacific CRO)Upgrade listing →
TFS HealthScienceUpgrade listing →
George ClinicalUpgrade listing →
Maxis Clinical SciencesUpgrade listing →
Paidion ResearchUpgrade listing →
Lata Medical ResearchUpgrade listing →
Veeda Clinical ResearchUpgrade listing →
Ecron AcunovaUpgrade listing →
Lambda Therapeutic ResearchUpgrade listing →
Pluto BiosciencesUpgrade listing →
Definiens ClinicalUpgrade listing →
JSS Medical ResearchUpgrade listing →
Hangzhou TaconUpgrade listing →
dMed BioscienceUpgrade listing →
BioPharma ServicesUpgrade listing →
Lotus Clinical ResearchUpgrade listing →
Velocity Clinical ResearchUpgrade listing →
Compass ResearchUpgrade listing →
Quotient SciencesUpgrade listing →
PAREXEL Early PhaseUpgrade listing →
Nucleus NetworkUpgrade listing →
QPS (Quality Pharmaceutical Services)Upgrade listing →
Spaulding ClinicalUpgrade listing →
ICON Early PhaseUpgrade listing →
Precision for MedicineUpgrade listing →
Atlantic Research GroupUpgrade listing →
PharPoint ResearchUpgrade listing →
Clinical PathwaysUpgrade listing →
Champions OncologyUpgrade listing →
Sarah Cannon Research InstituteUpgrade listing →
TD2 (Translational Drug Dev)Upgrade listing →
Cancer Research UK CTUUpgrade listing →
Champions RWEUpgrade listing →
Quality Data ServiceUpgrade listing →
SGS Health ScienceUpgrade listing →
Eurofins ScientificUpgrade listing →
Frontage LaboratoriesUpgrade listing →
Pacific BiotechUpgrade listing →
Alliance PharmaUpgrade listing →
Pacific BioanalyticsUpgrade listing →
Intertek PharmaceuticalUpgrade listing →
ICON BioanalyticalUpgrade listing →
PPD Bioanalytical LabUpgrade listing →
ProPharma GroupUpgrade listing →
Navitas Life SciencesUpgrade listing →
Camargo PharmaceuticalUpgrade listing →
Nuventra Pharma SciencesUpgrade listing →
PAREXEL RegulatoryUpgrade listing →
Regulatory Compliance Assoc.Upgrade listing →
Halloran ConsultingUpgrade listing →
Lachman ConsultantsUpgrade listing →
Premier ConsultingUpgrade listing →
Greenleaf HealthUpgrade listing →
Cato ResearchUpgrade listing →
THREAD ResearchUpgrade listing →
Illingworth ResearchUpgrade listing →
Alcanza Clinical ResearchUpgrade listing →
Lindus HealthUpgrade listing →
Headlands ResearchUpgrade listing →
Clinical Trial MediaUpgrade listing →
Ora (Ophthalmic)Upgrade listing →
Ki Health PartnersUpgrade listing →
Premier ResearchUpgrade listing →
Charles River LaboratoriesUpgrade listing →
Cerba ResearchUpgrade listing →
CMAX Clinical ResearchUpgrade listing →
Scientia Clinical ResearchUpgrade listing →
START (Oncology)Upgrade listing →
NEXT OncologyUpgrade listing →
KCAS BioanalyticalUpgrade listing →
Nucro-TechnicsUpgrade listing →
ELIQUENT Life SciencesUpgrade listing →

Contract Research Organizations: Frequently Asked Questions

How many CROs are in this directory?
This directory lists 143 contract research organizations (CROs) across seven categories: full service, early phase, oncology specialist, bioanalytical and lab, regulatory, decentralized trials, and specialty and niche. It is updated regularly by the BioMed Nexus editorial team.
Who are the largest CROs in 2026?
The largest contract research organizations include IQVIA, ICON, Fortrea, Parexel, Thermo Fisher (PPD), Syneos Health, Medpace and Charles River. They run clinical trials across all phases, therapeutic areas and geographies for pharma and biotech sponsors.
What is a CRO (contract research organization)?
A CRO (contract research organization) provides outsourced clinical research services to pharma, biotech and medical device companies, including trial design, site management, monitoring, data management, biostatistics, regulatory and laboratory services across preclinical and clinical phases.
What are the different types of CROs?
CROs range from large full-service global players to specialists in early-phase and Phase 1 studies, oncology, bioanalytical and central lab services, regulatory affairs, decentralized trials, and niche therapeutic areas. This directory organizes CROs by these seven categories.
What is the difference between a full-service and a niche CRO?
A full-service CRO manages entire clinical development programs across phases and regions, while a niche or specialty CRO focuses on a specific phase, therapeutic area or service such as oncology, ophthalmology or bioanalytical testing. Sponsors often combine both.
How can a CRO get listed or featured in the directory?
Any contract research organization can claim a free basic listing. Featured Partners receive priority placement at the top of the directory, a dedicated landing page, backlinks, and a featured segment in the BioMed Nexus daily newsletter reaching 65,000+ subscribers. Spots are limited, so contact the BioMed Nexus partnerships team to learn more.
Be the First Featured CRO

Get Your CRO in Front of 65,000+ Biotech Professionals

Right now, every CRO in this directory is just a name in a database. Featured partners get a full profile with logo, therapeutic expertise, service capabilities, backlinks, and priority placement at the very top of this page, seen by 65,000+ biotech professionals every week. Claim the top spot before your competitors do.

About the Contract Research Organizations (CRO) Directory

The BioMed Nexus Contract Research Organizations (CRO) Directory is a comprehensive, regularly updated list of CROs serving the pharma, biotech and medical device industry, spanning full-service global CROs, early-phase and Phase 1 units, oncology specialists, bioanalytical and central labs, regulatory CROs, decentralized trial providers, and specialty and niche CROs. It covers the largest global CROs alongside mid-size and specialist providers.

Use it to research CROs by service and specialty, shortlist clinical development partners, and compare large full-service players against niche specialists. Whether you are a biotech outsourcing a trial, a sponsor sourcing bioanalytical or regulatory services, or a business development lead mapping the CRO landscape, the directory provides structured, current CRO data. Curated and maintained by the BioMed Nexus editorial team; last updated July 2026.

CROs can claim a free basic listing or become a Featured Partner for priority placement, a dedicated landing page, backlinks, and a featured segment in the BioMed Nexus daily newsletter reaching 65,000+ subscribers. Contact our partnerships team to learn more.

Join 65,000+ Biotech, MedTech, and Pharma Leaders

Your Daily Edge in Biotech, MedTech, and Pharma

Get trusted, high-signal updates every morning
Breakthroughs, trial data, deals, and the news that matters